BXP vs SER · rev $3.48B vs rev $56.0K
Boston Properties Inc (BXP) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
BXP currently screens at market cap $12.12B. SER currently screens at market cap $29.7M.
Not investment advice. Open the BXP and SER stock pages for the full models.
Not investment advice.